|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.02 CAD | -20.00% |
|
-20.00% | 0.00% |
| 05-13 | Blackhawk Growth Corp. Reports Earnings Results for the Nine Months Ended March 31, 2024 | CI |
| 04-17 | Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI Technology | CI |
Blackhawk Growth Corp. reported earnings results for the nine months ended March 31, 2024. For the nine months, the company reported negative revenue was CAD 1.5 million compared to CAD 0.281001 million a year ago.
Net loss was CAD 1.6 million compared to CAD 1.36 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 1.14M | |
| +27.68% | 95.32B | |
| -5.16% | 94.46B | |
| +13.90% | 26.96B | |
| -9.40% | 17.17B | |
| -2.68% | 14.33B | |
| +0.65% | 13.61B | |
| -23.80% | 12.02B | |
| +26.19% | 10.53B | |
| +19.66% | 9.19B |
BLACKHAWK GROWTH CORP. 
